Jacobs & Co’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $516K | Sell |
4,090
-139
| -3% | -$18.3K | 0.04% | 95 |
|
|
2026
Q1 | $589K | Sell |
4,229
-33
| -0.8% | -$4.62K | 0.06% | 94 |
|
|
2025
Q4 | $523K | Sell |
4,262
-288
| -6% | -$35K | 0.05% | 95 |
|
|
2025
Q3 | $505K | Sell |
4,550
-25
| -0.5% | -$2.84K | 0.05% | 95 |
|
|
2025
Q2 | $507K | Sell |
4,575
-315
| -6% | -$33.5K | 0.05% | 97 |
|
|
2025
Q1 | $547K | Sell |
4,890
-275
| -5% | -$28.4K | 0.06% | 96 |
|
|
2024
Q4 | $477K | Sell |
5,165
-580
| -10% | -$52.2K | 0.05% | 98 |
|
|
2024
Q3 | $481K | Sell |
5,745
-4,877
| -46% | -$372K | 0.05% | 99 |
|
|
2024
Q2 | $728K | Sell |
10,622
-16,640
| -61% | -$1.11M | 0.08% | 93 |
|
|
2024
Q1 | $2M | Buy |
27,262
+725
| +3% | +$55.8K | 0.21% | 83 |
|
|
2023
Q4 | $2.15M | Sell |
26,537
-784
| -3% | -$61K | 0.24% | 84 |
|
|
2023
Q3 | $2.05M | Buy |
27,321
+35
| +0.1% | +$2.69K | 0.26% | 85 |
|
|
2023
Q2 | $2.1M | Buy |
27,286
+105
| +0.4% | +$8.37K | 0.25% | 85 |
|
|
2023
Q1 | $2.25M | Buy |
27,181
+195
| +0.7% | +$16.2K | 0.28% | 82 |
|
|
2022
Q4 | $2.32M | Buy |
26,986
+127
| +0.5% | +$10.1K | 0.3% | 80 |
|
|
2022
Q3 | $1.66M | Buy |
26,859
+560
| +2% | +$35.3K | 0.24% | 84 |
|
|
2022
Q2 | $1.63M | Buy |
26,299
+775
| +3% | +$48K | 0.22% | 84 |
|
|
2022
Q1 | $1.52M | Buy |
25,524
+1,835
| +8% | +$117K | 0.17% | 84 |
|
|
2021
Q4 | $1.72M | Sell |
23,689
-4,400
| -16% | -$303K | 0.18% | 82 |
|
|
2021
Q3 | $1.96M | Hold |
28,089
| – | – | 0.23% | 80 |
|
|
2021
Q2 | $1.93M | Buy |
28,089
+525
| +2% | +$35.1K | 0.22% | 80 |
|
|
2021
Q1 | $1.78M | Sell |
27,564
-1,120
| -4% | -$72.2K | 0.22% | 79 |
|
|
2020
Q4 | $1.67M | Buy |
28,684
+735
| +3% | +$44.4K | 0.22% | 77 |
|
|
2020
Q3 | $1.77M | Buy |
27,949
+5,595
| +25% | +$388K | 0.26% | 75 |
|
|
2020
Q2 | $1.72M | Buy |
22,354
+2,100
| +10% | +$161K | 0.28% | 76 |
|
|
2020
Q1 | $1.51M | Sell |
20,254
-150
| -0.7% | -$10.4K | 0.29% | 76 |
|
|
2019
Q4 | $1.32M | Sell |
20,404
-847
| -4% | -$55.2K | 0.2% | 81 |
|
|
2019
Q3 | $1.35M | Sell |
21,251
-2,003
| -9% | -$131K | 0.22% | 83 |
|
|
2019
Q2 | $1.57M | Sell |
23,254
-385
| -2% | -$25.3K | 0.25% | 84 |
|
|
2019
Q1 | $1.54M | Sell |
23,639
-1,535
| -6% | -$102K | 0.26% | 84 |
|
|
2018
Q4 | $1.57M | Buy |
25,174
+44
| +0.2% | +$3.08K | 0.31% | 78 |
|
|
2018
Q3 | $1.94M | Sell |
25,130
-2,907
| -10% | -$220K | 0.33% | 79 |
|
|
2018
Q2 | $1.99M | Sell |
28,037
-130
| -0.5% | -$9.18K | 0.36% | 79 |
|
|
2018
Q1 | $2.12M | Buy |
28,167
+295
| +1% | +$23.5K | 0.39% | 77 |
|
|
2017
Q4 | $2M | Sell |
27,872
-200
| -0.7% | -$15.2K | 0.36% | 79 |
|
|
2017
Q3 | $2.27M | Buy |
28,072
+2
| +0% | +$153 | 0.43% | 77 |
|
|
2017
Q2 | $1.99M | Sell |
28,070
-1,892
| -6% | -$126K | 0.39% | 78 |
|
|
2017
Q1 | $2.04M | Sell |
29,962
-3,500
| -10% | -$246K | 0.42% | 78 |
|
|
2016
Q4 | $2.4M | Sell |
33,462
-626
| -2% | -$46.5K | 0.52% | 72 |
|
|
2016
Q3 | $2.7M | Buy |
34,088
+148
| +0.4% | +$12K | 0.6% | 67 |
|
|
2016
Q2 | $2.83M | Buy |
33,940
+380
| +1% | +$33.7K | 0.67% | 63 |
|
|
2016
Q1 | $3.08M | Sell |
33,560
-292
| -0.9% | -$26.3K | 0.74% | 55 |
|
|
2015
Q4 | $3.29M | Buy |
33,852
+1,116
| +3% | +$116K | 0.85% | 50 |
|
|
2015
Q3 | $3.21M | Buy |
32,736
+746
| +2% | +$82.9K | 0.85% | 48 |
|
|
2015
Q2 | $3.75M | Buy |
31,990
+60
| +0.2% | +$6.56K | 0.94% | 48 |
|
|
2015
Q1 | $3.13M | Buy |
31,930
+2,285
| +8% | +$232K | 0.79% | 55 |
|
|
2014
Q4 | $2.79M | Buy |
29,645
+1,240
| +4% | +$128K | 0.74% | 57 |
|
|
2014
Q3 | $3.02M | Sell |
28,405
-485
| -2% | -$47.5K | 0.86% | 54 |
|
|
2014
Q2 | $2.4M | Buy |
28,890
+110
| +0.4% | +$8.56K | 0.69% | 62 |
|
|
2014
Q1 | $2.04M | Sell |
28,780
-280
| -1% | -$22K | 0.63% | 64 |
|
|
2013
Q4 | $2.18M | Sell |
29,060
-2,365
| -8% | -$165K | 0.7% | 60 |
|
|
2013
Q3 | $1.98M | Sell |
31,425
-230
| -0.7% | -$13.7K | 0.69% | 59 |
|
|
2013
Q2 | $1.62M | Buy |
+31,655
| New | +$1.65M | 0.59% | 66 |
|
Other funds holding GILD
Jacobs & Co's GILD Position: Q2 2026 in Review
Jacobs & Co reduced its Gilead Sciences (GILD) stake by 3.3% in Q2 2026, selling an estimated $18.3K and leaving 4,090 shares worth $516K. The position accounts for 0.04% of the portfolio, ranked #95.
Jacobs & Co first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.75M in Q2 2015. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Jacobs & Co held 4,090 shares of Gilead Sciences worth $516K as of Q2 2026.
- Jacobs & Co sold 139 Gilead Sciences shares in Q2 2026, an estimated $18.3K.
- Gilead Sciences made up 0.04% of Jacobs & Co's portfolio in Q2 2026, its #95 holding.
- Jacobs & Co first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Jacobs & Co's Gilead Sciences position peaked at $3.75M in Q2 2015.
- 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Jacobs & Co's 13F filing for Q2 2026, filed 9 Jul 2026.